RadioTransNet:由SFRO与SFPM协调的临床前研究网络
RadioTransNet项目由法国放射肿瘤学会(SFRO)和医学物理学会(SFPM)发起,于2018年12月获法国国家癌症研究所(INCa)批准,旨在建立具有明确优先研究领域的国家级横向临床前研究结构,涵盖放射肿瘤学转化研究。其活动由包含放射肿瘤学家、医学物理学家和学术生物学家的科学委员会协调,围绕靶区定义、放射与正常组织相互作用、联合治疗和现代剂量计算方法等主要领域展开。
要点
- 项目由SFRO和SFPM发起,2018年12月获INCa批准。
- 优先研究领域包括靶区定义、放射与正常组织相互作用、联合治疗及现代剂量计算。
- 设立四个工作包,涉及基础放射生物学、新药临床前早期应用及影像贡献。
核心结论
- RadioTransNet项目获INCa批准,旨在提出一个包含放射肿瘤学转化研究的国家级横向临床前研究结构,并具有明确的优先研究领域。
- 项目活动由包含放射肿瘤学家、医学物理学家和学术生物学家的科学委员会协调,围绕若干主要领域展开。
- 所有任务将纳入一个利用参与伙伴互补专长的国家网络,通过科学理事会遴选提案并向INCa及各学术协会申请资助。
研究设计与样本
- 项目由法国放射肿瘤学会(SFRO)和医学物理学会(SFPM)发起,于2018年12月获法国国家癌症研究所(INCa)批准。
- 活动由包含放射肿瘤学家、医学物理学家和学术生物学家的科学委员会协调。
- 围绕靶区定义、放射与正常组织相互作用、联合治疗和现代剂量计算方法四个主要领域设立四个工作包。
- 工作包与其他目标相关联,包括基础放射生物学、新药临床前早期应用、影像在该任务中的贡献、医学物理研究(含医学肿瘤学、放射学、核医学等横向组件)及成本/效率评估。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The RadioTransNet programme launched under the auspices of French societies for radiation oncology (SFRO) and medical physics (SFPM) was approved by the French national cancer institute (INCa) in December 2018 and is dedicated to proposing a relevant national and transversal structure for preclinical research including translational research in radiation oncology with well-defined priority areas of research. Its activities, coordinated by a scientific committee that includes radiation oncologists, medical physicists, academic biologists, are structured around several main areas, i.e.: target volume definition, interaction of radiation with normal tissues, combined treatments and modern dose calculation approaches. Four work packages have been created in these areas and are associated with other objectives pertaining to fundamental radiobiology, early implementation of new drugs in a preclinical setting, contribution of imaging in this task, research in medical physics including transversal components such as medical oncology, radiology, nuclear medicine and also cost/efficiency evaluation. All these tasks will be included in a national network that uses the complementary expertise provided by partners involved in the scheme. Calls for proposals will be selected by the scientific council to be submitted to INCa and the various academic associations to obtain funding for the human and technical resources required to conduct under optimal conditions projects in preclinical and translational research in radiation-oncology.
引用
- Maingon, Marchesi, Azria, et al. RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM. Cancer Radiother. 2021. PMID: 34862132. doi:10.1016/j.canrad.2021.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。